Isolated bulbar phenotype of amyotrophic lateral sclerosis

References

• Swash M, Desai J. Motor neuron disease: classification and nomenclature. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;2:105–12.
   Google Scholar
• Sorenson EJ, Stalker AP, Kurland LT, Windebank AJ. Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998. Neurology. 2002;59:280–2.
   PubMed Web of Science ®Google Scholar
• Millul A, Beghi E, Logroscino G, Micheli A, Vitelli E, Zardi A. Survival of patients with amyotrophic lateral sclerosis in a population based registry. Neuroepidemiology. 2005;25: 114–9.
   PubMed Web of Science ®Google Scholar
• Magnus T, Beck M, Giess R, Puls I, Naumann M, Toyka K. Disease progression in amyotrophic lateral sclerosis: predictors of survival. Muscle & Nerve. 2002;25:709–14.
   PubMed Web of Science ®Google Scholar
• del Aguila M, Longstreth W, McGuire V, Koepsell T, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population based study. Neurology. 2003;60:813–9.
   PubMed Web of Science ®Google Scholar
• Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, . Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2008;10:1–14.
   Google Scholar
• Gordon PH, Cheng B, Katz IB, Pinto M, Hays AP, Mitsumoto H, . The natural history of primary lateral sclerosis. Neurology. 2006;66:647–53.
   PubMed Web of Science ®Google Scholar
• Wijesekera LC, Mathers S, Talman P, Galtrey C, Parkinson MH, Ganesalingam J, . Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology. 2009;72: 1087–94.
   PubMed Web of Science ®Google Scholar
• Duchenne G, Poore GV, Society NS. Selections from the clinical works of Dr. Duchenne (de Boulogne). New Sydenham Society; 1883.
   Google Scholar
• Rosenfeld J, Swash M. What's in a name? Lumping or splitting ALS, PLS, PMA, and the other motor neuron diseases. Neurology. 2006;66:624–5.
   PubMed Web of Science ®Google Scholar
• Vucic S, Nicholson GA, Kiernan MC. Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. Brain. 2008;131:1540–50.
   PubMed Web of Science ®Google Scholar
• Duffy JR, Peach RK, Strand EA. Progressive apraxia of speech as a sign of motor neuron disease. American Journal of Speech-Language Pathology. 2007;16:198.
   PubMed Web of Science ®Google Scholar
• de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, . Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol. 2008;119:497–503.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Samarelli V, . Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study. Journal of Neurology, Neurosurgery & Psychiatry. 2008; 79:33–7.
   PubMed Web of Science ®Google Scholar
• Zoccolella S, Beghi E, Serlenga L, Logroscino G. Classification of amyotrophic lateral sclerosis cases at presentation in epidemiological studies. Neurol Sci. 2005;26: 330–3.
   PubMed Web of Science ®Google Scholar
• de Carvalho M, Scotto M, Lopes A, Swash M. Clinical and neurophysiological evaluation of progression in amyotrophic lateral sclerosis. Muscle Nerve. 2003;28:630–3.
   PubMed Web of Science ®Google Scholar
• Swash M, de Carvalho M. The Neurophysiological Index in ALS. Amyotroph Lateral Scler. 2004;5:108–10.
   PubMed Web of Science ®Google Scholar
• Mitsumoto H, Ulug AM, Pullman SL, Gooch CL, Chan S, Tang M, . Quantitative objective markers for upper and lower motor neuron dysfunction in ALS. Neurology. 2007; 68:1402–10.
   PubMed Web of Science ®Google Scholar
• Vucic S, Howells J, Trevillion L, Kiernan MC. Assessment of cortical excitability using threshold tracking techniques. Muscle Nerve. 2006;33:477–86.
   PubMed Web of Science ®Google Scholar
• Fisher RJ, Nakamura Y, Bestmann S, Rothwell JC, Bostock H. Two phases of intracortical inhibition revealed by transcranial magnetic threshold tracking. Exp Brain Res. 2002; 143:240–8.
   PubMed Web of Science ®Google Scholar
• Robinson LR, Jantra P, MacLean IC. Central motor conduction times using transcranial stimulation and F-wave latencies. Muscle & Nerve. 1988;11:174–80.
   PubMed Web of Science ®Google Scholar
• Cantello R, Gianelli M, Civardi C, Mutani R. Magnetic brain stimulation: the silent period after the motor evoked potential. Neurology. 1992;42:1951–9.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial ‘Clinical limits of amyotrophic lateral sclerosis’ workshop contributors. J Neurol Sci. 1994;124:96–107.
   PubMed Web of Science ®Google Scholar
• Miller RG, Munsat TL, Swash M, Brooks BR. Consensus guidelines for the design and implementation of clinical trials in ALS. World Federation of Neurology Committee on Research. J Neurol Sci. 1999;169:2–12.
   PubMed Web of Science ®Google Scholar
• Lapiedra RC, Lopez LA. Gomez GC. Progressive bulbar palsy: a case report diagnosed by lingual symptoms. Journal of Oral Pathology & Medicine. 2002;31:277.
   PubMed Web of Science ®Google Scholar
• Talacko AA, Reade PC. Progressive bulbar palsy: a case report of a type of motor neuron disease presenting with oral symptoms. Oral Surg Oral Med Oral Pathol. 1990;69:182–4.
   PubMedGoogle Scholar
• Hodkinson HM. More favourable prognosis of motor neuron disease in old age. Age Ageing. 1972;1:182–4.
   PubMedGoogle Scholar
• Becker A, Hardmeier M, Steck AJ, Czaplinski A. Primary lateral sclerosis presenting with isolated progressive pseudobulbar syndrome. European Journal of Neurology. 2007; 14:3.
   Web of Science ®Google Scholar
• Argyriou AA, Polychronopoulos P, Papapetropoulos S, Ellul J, Andriopoulos I, Katsoulas G, . Clinical and epidemiological features of motor neuron disease in south-western Greece. Acta Neurologica Scandinavica. 2005;111: 108–13.
   PubMed Web of Science ®Google Scholar
• Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland, 1995–1997: a population based study. Neurology. 1999;52:504.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Beghi E, Zoccolella S, Palagano R, Fraddosio A, Simone IL, . Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study. J Neurol Neurosurg Psychiatry. 2005;76:1094–8.
   PubMed Web of Science ®Google Scholar
• Norris F, Shepherd R, Denys E, U K, Mukai E, Elias L, . Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci. 1993;118:48–55.
   PubMed Web of Science ®Google Scholar
• Granieri E, Carreras M, Tola R, Paolino E, Tralli G, Eleopra R, . Motor neuron disease in the province of Ferrara, Italy, in 1964-1982. Neurology. 1988;38:1604.
   PubMed Web of Science ®Google Scholar
• Forsgren L, Almay BGL, Wall S. Epidemiology of motor neuron disease in northern Sweden. Acta Neurologica Scandinavica. 1983;68:20–9.
   PubMed Web of Science ®Google Scholar
• Vucic S, Kiernan MC. Abnormalities in cortical and peripheral excitability in flail arm variant amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2007;78:849–52.
   PubMed Web of Science ®Google Scholar
• Vucic S, Kiernan MC. Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease. Brain. 2006;129:2436–46.
   PubMed Web of Science ®Google Scholar
• Ziemann U. TMS and drugs. Clinical Neurophysiology. 2004; 115:1717–29.
   PubMed Web of Science ®Google Scholar
• Ziemann U. Cortical threshold and excitability measurements. Dr Andrew Eisen editor, Department of Neurology, University of British Columbia, Vancouver General Hospital, Vancouver, Canada. Elsevier (Amsterdam, Netherlands): 2004. 317–35.
   Google Scholar
• Ziemann U, Lönnecker S, Steinhoff BJ, Paulus W. The effect of lorazepam on motor cortical excitability in man. Exp Brain Res. 1996;109:127–35.
   PubMed Web of Science ®Google Scholar
• Vucic S, Cheah BC, Krishnan AV, Burke D, Kiernan MC. The effects of alterations in conditioning stimulus intensity on short interval intracortical inhibition. Brain Res. 2009; 1273:39–47.
   PubMed Web of Science ®Google Scholar
• Vucic S, Kiernan MC. Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease. Brain. 2006;129:2436–46.
   PubMed Web of Science ®Google Scholar
• Zanette G, Tamburin S, Manganotti P, Refatti N, Forgione A, Rizzuto N. Different mechanisms contribute to motor cortex hyperexcitability in amyotrophic lateral sclerosis. Clinical Neurophysiology. 2002;113:1688–97.
   PubMed Web of Science ®Google Scholar
• Yokota T, Yoshino A, Inaba A, Saito Y. Double cortical stimulation in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatr. 1996;61:596–600.
   PubMed Web of Science ®Google Scholar
• Ziemann U, Winter M, Reimers CD, Reimers K, Tergau F, Paulus W. Impaired motor cortex inhibition in patients with amyotrophic lateral sclerosis: evidence from paired transcranial magnetic stimulation. Neurology. 1997;49:1292–8.
   PubMed Web of Science ®Google Scholar
• Hanajima R, Ugawa Y, Terao Y, Ogata K, Kanazawa I. Ipsilateral cortico-cortical inhibition of the motor cortex in various neurological disorders. J Neurol Sci. 1996;140:109–16.
   PubMed Web of Science ®Google Scholar
• Stefan K, Kunesch E, Benecke R, Classen J. Effects of riluzole on cortical excitability in patients with amyotrophic lateral sclerosis. Ann Neurol. 2001;49:536–9.
   PubMed Web of Science ®Google Scholar
• van den Bosch L, van Damme P, Bogaert E, Robberecht W. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. BBA-Molecular Basis of Disease. 2006; 1762:1068–82.
   PubMed Web of Science ®Google Scholar
• Nihei K, McKee AC, Kowall NW. Patterns of neuronal degeneration in the motor cortex of amyotrophic lateral sclerosis patients. Acta Neuropathol. 1993;86:55–64.
   PubMed Web of Science ®Google Scholar
• Floyd AG, Yu QP, Piboolnurak P, Tang MX, Fang Y, Smith WA, . Transcranial magnetic stimulation in ALS: utility of central motor conduction tests. Neurology. 2009;72:498–504.
   PubMed Web of Science ®Google Scholar
• Miscio G, Pisano F, Mora G, Mazzini L. Motor neuron disease: usefulness of transcranial magnetic stimulation in improving the diagnosis. Clin Neurophysiol. 1999;110:975–81.
   PubMed Web of Science ®Google Scholar